EU Committee Upholds Negative Opinions On Cimzia, Rhucin Applications
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharming will use new Rhucin trial data to support BLA, European appeal.
You may also be interested in...
UCB’s Cimzia Priced At Discount To Humira
Launch strategy for the anti-TNF in Crohn’s disease includes free trials, co-pay assistance, UCB says.
UCB’s Cimzia Priced At Discount To Humira
Launch strategy for the anti-TNF in Crohn’s disease includes free trials, co-pay assistance, UCB says.
Jerini’s Icatibant Falters in U.S., Wins In Europe
FDA rejects orphan drug for hereditary angioedema, paving way for rivals to gain an edge.